raises IGF-1 and carries glucose-tolerance risk Compound Semaglutide (Wegovy) Class GLP-1 receptor agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
THE PRODUCTS DESCRIBED HEREIN ARE FOR RESEARCH USE ONLY
The takeaway is that lipotropic injections enhance the bodys natural fat-burning processes, but they produce the best results when paired with caloric deficit, physical activity, and other supportive treatments like slimming shots
While AOD9604 is often marketed as a targeted fat burner, peptides like CJC1295, Tesamorelin, and 5Amino1MQ work through different pathways and may deliver stronger results depending on individual goals
The injection takes just a few seconds and is generally well-tolerated, with most patients describing it as a brief pinch
Integrative Medicine: A Clinicians Journal